Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

Abstract

Patients with simple steatosis may still develop NASH and fibrosis progression. Weight reduction is associated with non-progressive disease. All patients with NAFLD should undergo periodic assessment and lifestyle modification.

Keywords

SteatohepatitisMedicineFatty liverInternal medicineSteatosisLiver biopsyGastroenterologyProspective cohort studyBody mass indexFibrosisDiseaseBiopsy

Affiliated Institutions

Chinese University of Hong Kong HK

Related Publications

Non‐alcoholic steatohepatitis: Definitions and pathogenesis

CP Day , S SAKSENA

The term 'non-alcoholic steatohepatitis' or NASH was first used by Ludwig et al. in 1980 to describe 'the pathological and clinical features of non-alcoholic disease of the live...

2002 Journal of Gastroenterology and Hepat... 187 citations

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Gregory C. Vernon , Ancha Baranova , Zobair M. Younossi

Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence co...

2011 Alimentary Pharmacology & Therapeutics 3042 citations

Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies

E Fassio , Estela �lvarez , Nora Dom�nguez +2 more

Nonalcoholic steatohepatitis may cause severe fibrosis, cirrhosis, and hepatocellular carcinoma, but supporting evidence is based on indirect data. Few publications have examine...

2004 Hepatology 469 citations

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

Zobair M. Younossi , Maria Stepanova , Nila Rafiq +4 more

Since the initial description of nonalcoholic steatohepatitis (NASH), several sets of pathologic criteria for its diagnosis have been proposed. However, their interprotocol agre...

2011 Hepatology 616 citations

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡

Kittichai Promrat , Glen Lutchman , Gabriel I. Uwaifo +11 more

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibr...

2004 Hepatology 723 citations

Publication Info

Year: 2010
Type: article
Volume: 59
Issue: 7
Pages: 969-974
Citations: 638
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

638

OpenAlex

Cite This

APA Style

                            
                                
                                    Victoria Wong, 
                                
                                    Grace Lai‐Hung Wong, 
                                
                                    Paul C.L. Choi
                                
                                et al.
                            
                            (2010). 
                            Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. 
                            Gut
                            , 59
                            (7)
                            , 969-974.
                            https://doi.org/10.1136/gut.2009.205088
                        

Identifiers

DOI: 10.1136/gut.2009.205088